Search
 

Pharmacies lobby FDA for right to keep making weight-loss drugs

A pharmacy group says compounding the two GLP-1 agonists, now commercially available, is not that hard.

By Allison Bell | November 18, 2024 at 11:30 AM

Wegovy semaglutide injection pens. Credit: K KStock/Adobe Stock

Pharmacies that make customized medications are asking the federal Food and Drug Administration to protect their right to create homemade versions of Wegovy, Zepbound and other GLP-1 agonist weight-loss drugs.

The Alliance for Pharmacy Compounding is asking patients to use an online letter-writing system to tell the FDA that they want the agency to continue to let compounding pharmacies compound the two GLP-1 agonists now commercially available, semaglutide and tirzepatide.

Complete your profile to continue reading and get FREE access to BenefitsPRO.com, part of your ALM digital membership.

Your access to unlimited BenefitsPRO.com content isn’t changing.
Once you are an ALM digital member, you’ll receive:

  • Critical BenefitsPRO.com information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events.
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com

Already have an account?

NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

BenefitsPRO

Join BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join BenefitsPRO.com now!

  • Unlimited access to BenefitsPRO.com - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
  • Exclusive discounts on BenefitsPRO.com and ALM events.

Already have an account? Sign In Now
Join BenefitsPRO

Copyright © 2024 ALM Global, LLC. All Rights Reserved.